c-Jun N-TERMINAL KINASE BINDING DOMAIN-DEPENDENT PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 AND MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 AND BALANCING CROSS-TALK BETWEEN c-Jun N-TERMINAL KINASE AND EXTRACELLULAR SIGNAL-REGULATED KINASE PATHWAYS IN CORTICAL NEURONS

被引:37
|
作者
Repici, M. [2 ]
Mare, L. [2 ]
Colombo, A. [1 ]
Ploia, C. [1 ]
Sclip, A. [1 ]
Bonny, C. [3 ]
Nicod, P. [3 ]
Salmona, M. [1 ]
Borsello, T. [1 ,2 ]
机构
[1] Ist Ric Farmacol Mario Negri, Biol Neurodeg Disorders Lab, Neuronal Death & Neuroprotect Unit, I-20156 Milan, Italy
[2] Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland
[3] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
JNK; MKK4; MKK7; ERK; MEK1; D-JNKI1; PEPTIDE INHIBITOR; CELL-DEATH; DOCKING SITES; NH2-TERMINAL KINASE; CEREBRAL-ISCHEMIA; DOWN-REGULATION; HEARING-LOSS; JNK; TRANSDUCTION; INJURY;
D O I
10.1016/j.neuroscience.2008.11.049
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The c-Jun N-terminal kinase (JNK) is a mitogen-activated protein kinase (MAPK) activated by stress-signals and involved in many different diseases. Previous results proved the powerful effect of the cell permeable peptide inhibitor D-JNKI1 (D-retro-inverso form of c-Jun N-terminal kinase-inhibitor) against neuronal death in CNS diseases, but the precise features of this neuroprotection remain unclear. We here performed cell-free and in vitro experiments for a deeper characterization of D-JNKI1 features in physiological conditions. This peptide works by preventing JNK interaction with its c-Jun N-terminal kinase-binding domain (JBD) dependent targets. We here focused on the two JNK upstream MAPKKs, mitogen-activated protein kinase kinase 4 (MKK4) and mitogen-activated protein kinase kinase 7 (MKK7), because they contain a JBD homology domain. We proved that D-JNKI1 prevents MKK4 and MKK7 activity in cell-free and in vitro experiments: these MAPKK could be considered not only activators but also substrates of JNK. This means that D-JNKI1 can interrupt downstream but also upstream events along the JNK cascade, highlighting a new remarkable feature of this peptide. We also showed the lack of any direct effect of the peptide on p38, MEK1, and extracellular signal-regulated kinase (ERK) in cell free, while in rat primary cortical neurons JNK inhibition activates the MEK1-ERK-Ets1/c-Fos cascade. JNK inhibition induces a compensatory effect and leads to ERK activation via MEK1, resulting in an activation of the survival pathway(MEK1/ERK) as a consequence of the death pathway-(JNK) inhibition. This study should hold as an important step to clarify the strong neuroprotective effect of D-JNKI1. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:94 / 103
页数:10
相关论文
共 50 条
  • [31] Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli
    Foltz, IN
    Gerl, RE
    Wieler, JS
    Luckach, M
    Salmon, RA
    Schrader, JW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) : 9344 - 9351
  • [32] Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo:: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinase kinases 4 and 7
    Finch, A
    Davis, W
    Carter, WG
    Saklatvala, J
    BIOCHEMICAL JOURNAL, 2001, 353 : 275 - 281
  • [33] Targeting the MKK7-JNK (Mitogen-Activated Protein Kinase Kinase 7-c-Jun N-Terminal Kinase) Pathway with Covalent Inhibitors
    Wolle, Patrik
    Hardick, Julia
    Cronin, Shane J. F.
    Engel, Julian
    Baumann, Matthias
    Lategahn, Jonas
    Penninger, Josef M.
    Rauh, Daniel
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (05) : 2843 - 2848
  • [34] Involvement of protein kinase C and Src family tyrosine kinase in Gαq/11-induced activation of c-jun N-terminal kinase and p38 mitogen-activated protein kinase
    Nagao, M
    Yamauchi, J
    Kaziro, Y
    Itoh, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) : 22892 - 22898
  • [35] Activation of stress-activated protein kinases c-Jun N-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase kinase (MKK7)
    Yao, ZB
    Diener, K
    Wang, XS
    Zukowski, M
    Matsumoto, G
    Zhou, GS
    Mo, R
    Sasaki, T
    Nishina, H
    Hui, CC
    Tan, TH
    Woodgett, JP
    Penninger, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) : 32378 - 32383
  • [36] Thrombin-specific activation of c-jun N-terminal kinase and P38 mitogen-activated protein kinase in human liver cells
    Mitsui, H
    Maruyama, T
    Kimura, S
    Takuwa, Y
    HEPATOLOGY, 1997, 26 (04) : 546 - 546
  • [37] Mechanical stress induces mitogen-activated protein kinase (MAPK) phosphatase possibly through MAPK but not c-Jun N-terminal kinase in cardiac myocytes
    Kudoh, S
    Zou, YZ
    Hiroi, J
    Yamazaki, T
    CIRCULATION, 1996, 94 (08) : 1658 - 1658
  • [38] The stress-activated protein kinase pathways, c-Jun N-terminal kinase and P38-mitogen activated protein kinase, regulate fibronectin expression in aortic regurgitation
    Truter, SL
    Gupta, A
    Leer, EH
    Huang, Z
    Pitlor, LL
    Borer, JS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 353A - 353A
  • [39] Low concentrations of trichosanthin induce apoptosis and cell cycle arrest via c-Jun N-terminal protein kinase/mitogen-activated protein kinase activation
    Zhang, Duo
    Chen, Bin
    Zhou, Jian
    Zhou, Lin
    Li, Qing
    Liu, Fei
    Chou, Kuang-Yen
    Tao, Lei
    Lu, Li-Ming
    MOLECULAR MEDICINE REPORTS, 2015, 11 (01) : 349 - 356
  • [40] Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase
    Tamir, A
    Granot, Y
    Isakov, N
    JOURNAL OF IMMUNOLOGY, 1996, 157 (04): : 1514 - 1522